Scientists in lab coats work with green liquid in a research facility, focusing on biotechnological development.
Loopworm, a Bengaluru-based bio-manufacturing startup founded in 2019 by Ankit Alok Bagaria and Abhi Gawri, is leveraging insects like silkworms and black soldier flies to produce protein biologics for animal feed and pharmaceutical applications. The company’s approach aims to reduce the cost of manufacturing proteins by half to one-fifth, depending on the molecule and its production complexity.
The startup raised ₹25.8 Cr in September 2022 from Omnivore Ventures, followed by ₹27.8 Cr in June 2025 from Enrition Capital and Waterbridge Ventures. It also received early backing through grants from BIRAC’s Biotechnology Ignition Grant, Rashtriya Krishi Vikas Yojna (RKVY), Elevate Karnataka, Tata Trusts, the Gates Foundation and H&M Foundation.
Loopworm currently generates revenue from manufacturing protein for animal feed, processing insects into high-protein concentrates and Omega-3-rich fats. These are sold as ingredients for aquaculture, poultry, and pet food, with supplies to feed manufacturers in India and exports to Japan, Europe, and South America.
In FY25, Loopworm reported a revenue of ₹4.5 Cr and is projecting ₹15-18 Cr for FY26, led largely by export demand in animal nutrition. The company is also developing a biostimulant for crops and is conducting trials in collaboration with ICAR – IIPR for pulses to assess the product’s efficiency on Mungbean, Urdbean, and Chickpeas.
Loopworm is now focusing on producing specialized proteins for diagnostic and research use, including Green Fluorescent Protein (GFP). For FY26, Loopworm aims to nearly quadruple its topline on the back of growing demand for its animal nutrition products and the launch of its recombinant proteins.
About the Author
